Preoperative portal vein embolization (PVE) for patients with hepatocellular carcinoma can improve resectability and may improve disease-free survival

Journal of Surgical Oncology

Volumn 104, Issue 6, 2011, Pages 641-646

  Okabe, Hirohisa ^a   Beppu, Toru ^a   Ishiko, Takatoshi ^a   Masuda, Toshiro ^a   Hayashi, Hiromitsu ^a   Otao, Ryu ^a   Hasita, Horlad ^a   Okabe, Kazutoshi ^b   Sugiyama, Shinichi ^b   Baba, Hideo ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

^b NTT West Kyushu Hospital   (Japan)

Author keywords

future liver remnant; hepatic function; surgical stress; survival benefit

Indexed keywords

BILIRUBIN;

ADULT; ARTICLE; ARTIFICIAL EMBOLISM; ASCITES; BILE DUCT FISTULA; BILIRUBIN BLOOD LEVEL; BLEEDING; BLOOD TRANSFUSION; BLOOD VOLUME; CANCER PATIENT; CANCER SIZE; CANCER SURGERY; CANCER SURVIVAL; CLINICAL EFFECTIVENESS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; GASTROINTESTINAL HEMORRHAGE; HEMOPERITONEUM; HUMAN; LIVER CELL CARCINOMA; LIVER FAILURE; LIVER FIBROSIS; LIVER FUNCTION; LIVER RESECTION; LIVER SIZE; MAJOR CLINICAL STUDY; MALE; OPERATION DURATION; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PLEURA EFFUSION; PORTAL VEIN EMBOLIZATION; POSTOPERATIVE PERIOD; PREOPERATIVE CARE; PRIORITY JOURNAL; PROGNOSIS; PROTHROMBIN TIME; SURGICAL INFECTION; SURGICAL MORTALITY; SURVIVAL RATE;

AGED; CARCINOMA, HEPATOCELLULAR; EMBOLIZATION, THERAPEUTIC; FEMALE; FOLLOW-UP STUDIES; HEPATECTOMY; HUMANS; LIVER FUNCTION TESTS; LIVER NEOPLASMS; MALE; MIDDLE AGED; PORTAL VEIN; POSTOPERATIVE COMPLICATIONS; PREOPERATIVE CARE; PROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 80053610863     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.21928     Document Type: Article

References (35)

1. Farges O, Belghiti J, Kianmanesh R, et al.: Portal vein embolization before right hepatectomy: Prospective clinical trial. Ann Surg 2003; 237: 208-217. (Pubitemid 38173248)
2. Hemming AW, Reed AI, Howard RJ, et al.: Preoperative portal vein embolization for extended hepatectomy. Ann Surg 2003; 237: 686-691; discussion 691-693.
3. Giraudo G, Greget M, Oussoultzoglou E, et al.: Preoperative contralateral portal vein embolization before major hepatic resection is a safe and efficient procedure: A large single institution experience. Surgery 2008; 143: 476-482. (Pubitemid 351406381)
4. Imamura H, Shimada R, Kubota M, et al.: Preoperative portal vein embolization: An audit of 84 patients. Hepatology 1999; 29: 1099-1105. (Pubitemid 29168743)
5. Liu H, Fu Y,: Portal vein embolization before major hepatectomy. World J Gastroenterol 2005; 11: 2051-2054. (Pubitemid 40542645)
6. Makuuchi M, Thai BL, Takayasu K, et al.: Preoperative portal embolization to increase safety of major hepatectomy for hilar bile duct carcinoma: A preliminary report. Surgery 1990; 107: 521-527. (Pubitemid 20156653)
7. Ribero D, Abdalla EK, Madoff DC, et al.: Portal vein embolization before major hepatectomy and its effects on regeneration, resectability and outcome. Br J Surg 2007; 94: 1386-1394. (Pubitemid 350144388)
8. de Baere T, Roche A, Elias D, et al.: Preoperative portal vein embolization for extension of hepatectomy indications. Hepatology 1996; 24: 1386-1391. (Pubitemid 26399035)
9. Nagino M, Kamiya J, Nishio H, et al.: Two hundred forty consecutive portal vein embolizations before extended hepatectomy for biliary cancer: Surgical outcome and long-term follow-up. Ann Surg 2006; 243: 364-372. (Pubitemid 43327769)
10. Yamakado K, Takeda K, Matsumura K, et al.: Regeneration of the un-embolized liver parenchyma following portal vein embolization. J Hepatol 1997; 27: 871-880. (Pubitemid 27454831)
11. Tanaka H, Hirohashi K, Kubo S, et al.: Preoperative portal vein embolization improves prognosis after right hepatectomy for hepatocellular carcinoma in patients with impaired hepatic function. Br J Surg 2000; 87: 879-882. (Pubitemid 30487689)
12. Copeland GP, Jones D, Walters M,: POSSUM: A scoring system for surgical audit. Br J Surg 1991; 78: 355-360.
13. Haga Y, Ikei S, Ogawa M,: Estimation of physiologic ability and surgical stress (E-PASS) as a new prediction scoring system for postoperative morbidity and mortality following elective gastrointestinal surgery. Surg Today 1999; 29: 219-225. (Pubitemid 29119837)
14. Haga Y, Wada Y, Takeuchi H, et al.: Estimation of physiologic ability and surgical stress (E-PASS) for a surgical audit in elective digestive surgery. Surgery 2004; 135: 586-594. (Pubitemid 38879341)
15. Prytherch DR, Whiteley MS, Higgins B, et al.: POSSUM and Portsmouth POSSUM for predicting mortality. Physiological and operative severity score for the enumeration of mortality and morbidity. Br J Surg 1998; 85: 1217-1220.
16. Tekkis PP, McCulloch P, Steger AC, et al.: Mortality control charts for comparing performance of surgical units: Validation study using hospital mortality data. Br Med J 2003; 326: 786-788. (Pubitemid 36523582)
17. Tekkis PP, Prytherch DR, Kocher HM, et al.: Development of a dedicated risk-adjustment scoring system for colorectal surgery (colorectal POSSUM). Br J Surg 2004; 91: 1174-1182. (Pubitemid 39179462)
18. Lan AK, Luk HN, Goto S, et al.: Stress response to hepatectomy in patients with a healthy or a diseased liver. World J Surg 2003; 27: 761-764. (Pubitemid 37022384)
19. Sadamori H, Yagi T, Kanaoka Y, et al.: The analysis of the usefulness of laparoscopic microwave coagulation therapy for hepatocellular carcinoma in patients with poor hepatic reserve by serial measurements of IL-6, cytokine antagonists, and C-reactive protein. Surg Endosc 2003; 17: 510-514. (Pubitemid 36302340)
20. Balzan S, Belghiti J, Farges O, et al.: The "50-50 criteria" on postoperative day 5: An accurate predictor of liver failure and death after hepatectomy. Ann Surg 2005; 242: 824-828; discussion 828-829.
21. Paugam-Burtz C, Janny S, Delefosse D, et al.: Prospective validation of the "fifty-fifty" criteria as an early and accurate predictor of death after liver resection in intensive care unit patients. Ann Surg 2009; 249: 124-128.
22. Beppu T, Iwatsuki M, Okabe H, et al.: A new approach to percutaneous transhepatic portal embolization using ethanolamine oleate iopamidol. J Gastroenterol 2010; 45: 211-217.
23. Nakano H, Yoshida K, Takeuchi S, et al.: Liver scintigraphy is useful for selecting candidates for preoperative transarterial chemoembolization among patients with hepatocellular carcinoma and chronic liver disease. Am J Surg 1999; 178: 385-389. (Pubitemid 30001518)
24. Belghiti J, Guevara OA, Noun R, et al.: Liver hanging maneuver: A safe approach to right hepatectomy without liver mobilization. J Am Coll Surg 2001; 193: 109-111. (Pubitemid 32591631)
25. Sobin LH, Wittekind C,: TNM classification of malignant tumours, 6th edition. New York: JWS; 2002.
26. Oka Y, Nishijima J, Oku K, et al.: Usefulness of an estimation of physiologic ability and surgical stress (E-PASS) scoring system to predict the incidence of postoperative complications in gastrointestinal surgery. World J Surg 2005; 29: 1029-1033. (Pubitemid 41605768)
27. Azoulay D, Castaing D, Krissat J, et al.: Percutaneous portal vein embolization increases the feasibility and safety of major liver resection for hepatocellular carcinoma in injured liver. Ann Surg 2000; 232: 665-672.
28. Wilms C, Mueller L, Lenk C, et al.: Comparative study of portal vein embolization versus portal vein ligation for induction of hypertrophy of the future liver remnant using a mini-pig model. Ann Surg 2008; 247: 825-834. (Pubitemid 351591518)
29. Hirai I, Kimura W, Fuse A, et al.: Evaluation of preoperative portal embolization for safe hepatectomy, with special reference to assessment of nonembolized lobe function with 99mTc-GSA SPECT scintigraphy. Surgery 2003; 133: 495-506. (Pubitemid 36638221)
30. Sugai Y, Komatani A, Hosoya T, et al.: Response to percutaneous transhepatic portal embolization: New proposed parameters by 99mTc-GSA SPECT and their usefulness in prognostic estimation after hepatectomy. J Nucl Med 2000; 41: 421-425. (Pubitemid 30133959)
31. Palavecino M, Chun YS, Madoff DC, et al.: Major hepatic resection for hepatocellular carcinoma with or without portal vein embolization: Perioperative outcome and survival. Surgery 2009; 145: 399-405.
32. Yamanaka N, Okamoto E, Fujihara S, et al.: Do the tumor cells of hepatocellular carcinomas dislodge into the portal venous stream during hepatic resection? Cancer 1992; 70: 2263-2267.
33. Yang ZF, Ngai P, Ho DW, et al.: Identification of local and circulating cancer stem cells in human liver cancer. Hepatology 2008; 47: 919-928. (Pubitemid 351449683)
34. Yang ZF, Ho DW, Ng MN, et al.: Significance of CD90+ cancer stem cells in human liver cancer. Cancer Cell 2008; 13: 153-166. (Pubitemid 351163165)
35. Ichida F, Tsuji T, Omata M,: New Inuyama classification; new criteria for histological assessment of chronic hepatitis. Int Hepatol Commun 1996; 6: 112-119. (Pubitemid 27059904)